Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Neuland"

18 News Found

Neuland unveils refreshed brand identity
News | June 10, 2024

Neuland unveils refreshed brand identity

The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress


Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr
News | May 11, 2024

Neuland Laboratories posts Q4 FY24 consolidated PAT at Rs. 67.56 Cr

Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024


Briefs: Concord Biotech and Neuland Laboratories
Drug Approval | March 23, 2024

Briefs: Concord Biotech and Neuland Laboratories

The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483


Briefs: Neuland Laboratories, Cipla and Zydus
Drug Approval | February 20, 2023

Briefs: Neuland Laboratories, Cipla and Zydus

Cipla has received 8 inspectional observations in Form 483


Neuland Laboratories appoints Abhijit Majumdar as CFO
People | November 24, 2022

Neuland Laboratories appoints Abhijit Majumdar as CFO

He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others


Prasad Raghava Menon appointed Additional Director of Neuland Laboratories
People | November 01, 2022

Prasad Raghava Menon appointed Additional Director of Neuland Laboratories

Menon has over 41 years of diverse experience in some of the premier multinational and Indian companies in the chemical and power industry


Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites
News | June 09, 2025

Carbogen Amcis enters into a co-investment agreement of CHF 25+ million to expand Swiss sites

This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021


Carbogen Amcis AG signs co-investment agreement
Biotech | August 25, 2021

Carbogen Amcis AG signs co-investment agreement

The co-investment of CHF 4 million will result in capacity expansion and support the market introduction of the customer's lead compound